Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer
Access status:
Open Access
Type
ArticleAuthor/s
King, MTStockler, MR
Butow, PN
O’Connell, R
Voysey, M
Oza, AM
Gillies, K
Donovan, HS
Mercieca-Bebbe, R
Martyn, J
Sjoquist, K
Friedlander, ML
Date
2014-01-01Publisher
Lippincott, Williams & WilkinsLicence
This is not the final published version. The final published version can be found at http://dx.doi.org/10.1097/IGC.0000000000000167Citation
King MT, Stockler MR, Butow P, O’Connell R, Voysey M, Oza AM, Gillies K, Donovan HS, Mercieca-Bebber R, Martyn J, Sjoquist K, Friedlander ML. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. International Journal of Gynecological Cancer, 2014; 24(5): 865-873.Share